Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coenzyme Q5, methyltransferase (COQ5) is a SAM-dependent methyltransferase enzyme located in the mitochondrial matrix, essential for the biosynthesis of ubiquinone (coenzyme Q10), a critical component of the mitochondrial electron transport chain responsible for ATP generation. COQ5 catalyzes the C-methylation of 2-decaprenyl-6-methoxy-1,4-benzoquinol (DDMQH2) to 2-decaprenyl-3-methyl-6-methoxy-1,4-benzoquinol (DMQH2), thus facilitating one of the final steps in the production of coenzyme Q10. Mutations in COQ5 can cause primary coenzyme Q10 deficiency leading to severe neurodevelopmental, neurological, and multi-organ dysfunctions. COQ5 is considered a core component of the multi-enzyme CoQ-synthome complex essential for mitochondrial metabolism, and its loss or dysfunction leads to marked biochemical and physiological defects.
Drugs that alter COQ5 would affect coenzyme Q10 biosynthesis by inhibiting or modulating methyltransferase activity during the conversion of intermediate benzoquinol substrates in the mitochondrial electron transport chain. (No direct drugs are reported in the sources.)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coenzyme Q5, methyltransferase (COQ5).